Document:

EX-10.7

 Exhibit 10.7 
 SETTLEMENT AND RELEASE 
 AGREEMENT 

DENNIS BROVARONE 
 and 
 PURE BIOSCIENCE, INC. 

EFFECTIVE DATE: 
 13 August 2013 

 SETTLEMENT AND RELEASE AGREEMENT 

I 

PARTIES 
 THIS SETTLEMENT AND RELEASE AGREEMENT (the “Agreement”) is entered into effective as of the 13th day of August, 2013 (the “Effective Date”), by and between DENNIS BROVARONE, an individual residing
in the State of California (“Brovarone”); and, PURE BIOSCIENCE, INC., a Delaware corporation (“PURE”). Brovarone and PURE are sometimes referred to collectively herein as the
“Parties”, and each individually as a “Party”. 
 II 

RECITALS 
 A. Brovarone serves as a member of the Board of Directors of PURE (the “Board”). 
 B. Brovarone has previously provided legal services to PURE in his capacity as an attorney. 
 C. As part of a reorganization and restructuring of PURE’s business, Brovarone’s position as a member of the Board and as an attorney for PURE is hereby terminated effective immediately
by the mutual agreement of the Parties. 
 D. Subject to the terms and conditions of this Agreement, Brovarone is willing
to and hereby does provide assurances to PURE that he will not assert any claims of any kind against PURE and specifically identified related parties, whether arising out of (i) Brovarone’s status as a member of the Board; or,
(ii) with the exception of rights of the Parties created in this Agreement, any other relationship or claim of right whatsoever arising out of or any manner or form related to the relationship between the Parties. 

E. This Agreement is to specifically encompass all of the claims and related factual and legal circumstances noted above,
including though not limited to all rights, duties, and obligations arising under Brovarone’s rendering of legal services to PURE (collectively referred to as the “Working Relationship”). As such, it is the intent of the
Parties that their respective rights and obligations to each other from this day forward shall be determined exclusively under the terms of this Agreement. 
 F. All Parties are desirous of settling all rights under the Working Relationship and releasing each other from all future liability, except as otherwise expressly provided herein to the contrary.

 G. NOW, THEREFORE, in consideration of the promises and the mutual covenants contained herein, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows: 
 III 
 RELEASE AND PAYMENT OBLIGATIONS 

3.1 Exchange. In consideration of (i) the execution of this Agreement; (ii) the satisfaction of PURE’s
obligations described below; (iii) the satisfaction of Brovarone’s obligations described below; and, (iv) other good and valuable consideration, the receipt and value of which is hereby confirmed, Brovarone on the one hand, and PURE
on the other hand, shall hereby fully, finally, and forever settle and release each other from any and all claims, losses, fines, penalties, damages, demands, judgments, debts, obligations, interests, liabilities, causes of action, breaches of duty,
costs, expenses, judgments and injunctions of any nature whatsoever, whether known or unknown, from all relationships between the Parties, specifically including, but not limited to, those arising under or as a result of the Working Relationship
(cumulatively referred to as the “Released Claims”). 

  
 1 

 3.2 Payment Obligations. Upon execution and delivery of this Agreement by
Brovarone and Brovarone’s termination of positions as envisioned hereunder, PURE shall pay to Brovarone as a “Separation Payment” the sum of Ninety One Thousand Three Hundred Thirty Two Dollars and Seventy Seven Cents
($91,332.77). Said Separation Payment shall be payable as follows: 
 (a) No interest shall be accrued and no payments shall be
made for the first 90-days after the Separation Date. 
 (b) After the first 90-days after the Separation Date two percent
(2%) simple interest per annum shall be applied to the Separation Payment. 
 (c) Payments of principal and interest shall
be made in sixty (60) monthly installments of One Thousand Six Hundred Dollars and Eighty Six Cents ($1,600.86) commencing one hundred twenty (120) days after the Separation Date, and continuing thereafter on the same day of each month
until the entire Separation Payment and all accrued interest have been paid in full. 
 (d) PURE shall have the right to make
payment on the Separation Payment, in whole or in part, at any time and from time to time without penalty; however, PURE shall provide Brovarone with thirty (30) days prior notice of prepayment greater than the monthly installment. 

(e) All payments of the Separation Payment, whether of principal or interest, or both, shall be made by PURE to Brovarone in the form of
check or wire transfer in accordance with written instructions provided by Brovarone. 
 (f) Brovarone hereby acknowledges and
agrees that the Separation Payment represents payment in full of all salary, wages, compensation, unreimbursed business expenses, pay, and any and all other amounts due and owing to Brovarone as of the Separation Date. Brovarone further acknowledges
and agrees that except as otherwise expressly provided for herein, no additional compensation or amounts of any kind are or will be due to Brovarone from PURE. 
 3.3 Conversion Right. Brovarone may at any time, in his sole and absolute discretion upon ten (10) days written notice to PURE (the “Conversion Notice”), convert the
Separation Payment and accrued interest, in whole or in part (though in no event for an amount less than Five Thousand Dollars), without any further action by Brovarone (other than the Conversion Notice), into common stock of PURE at a conversion
price equal to the average closing price for PURE common stock on the principal market on which PURE common stock is then listed or quoted for the ten trading (10) days immediately preceding the date of the Conversion Notice. Not later than
five (5) business days after receipt of the Conversion Notice PURE shall deliver, or cause to be delivered, to Brovarone the number of shares of PURE common stock being acquired under the Conversion Notice. 

3.4 Complete Release and Hold Harmless. Brovarone, on behalf of himself, his spouse, his heirs, personal representatives,
successors, assigns and all others claiming through or under him, and PURE, for itself and its successors and assigns, hereby agree to release, discharge, and hold harmless each other and their respective directors, officers, affiliates, and
attorneys, and each of their successors and assigns, from any and all known and unknown claims of every nature and kind whatsoever which they now or hereafter may have with respect to each other and/or the Released Claims, notwithstanding
Section 1542 of the California Civil Code, which provides that: 
 “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS
WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, AND WHICH IF KNOWN BY HIM, MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.” 

  
 2 

 All rights under §1542 of the California Civil Code are hereto expressly, fully,
knowingly and intentionally forever waived and relinquished by the Parties. All Parties hereby acknowledge that each understands the significance and consequences of such specific waiver under §1542 of the California Civil Code, and that each
has had the opportunity to seek the advice of legal counsel of their choosing. 
 3.5 Scope of Brovarone’s
Release. Brovarone further expressly understands that the rights being waived hereunder specifically include, but are not limited to, any and all claims under (as any of the same may be amended from time to time) Title VII of the Civil
Rights Act of 1964; Sections 1981 and 1983 of the Civil Rights Act of 1866; Equal Pay Act; Americans with Disabilities Act; Age Discrimination in Employment Act; Brovarone Retirement Income Security Act; Fair Labor Standards Act; Family and Medical
Leave Act; WARN Act; the United States and California Constitutions; California Fair Employment and Housing Act; California Family Rights Act; California Labor Code; any applicable California Industrial Welfare Commission Wage Order; with respect to
the foregoing constitutional and statutory references, any comparable constitution, statute or regulation of any other state; all claims of discrimination or harassment on account of race, sex, sexual orientation, national origin, religion,
disability, age, pregnancy, veteran’s status, or any other protected status under any federal or state statute; any federal, state or local law enforcing express or implied employment contracts or covenants of good faith and fair dealing; any
federal, state or local laws providing recourse for alleged wrongful discharge or constructive discharge, termination in violation of public policy, tort, physical or personal injury, emotional distress, fraud, negligent misrepresentation,
defamation, and any similar or related claim; together with any claim under any other local, state or federal law or constitution governing employment, discrimination or harassment in employment, or the payment of wages or benefits, whether or not
now known, suspected or claimed, which Brovarone ever had, now has, or may claim to have as of the date of this Agreement. This Agreement and the scope of the release by Brovarone hereunder expressly includes any statutory claims, including, but
not limited to, claims under the Age Discrimination in Employment Act (the “ADEA”) and the Older Workers’ Benefit Protection Act (“OWBPA”), except that this Agreement does not waive rights or claims under the
ADEA which may arise after the Effective Date of this Agreement. 
 3.6 After Acquired Information. The
Parties acknowledge that they may hereafter discover information, facts, or circumstances different from or in addition to those which they now know or believe to be true. Except as otherwise provided herein to the contrary, this Agreement shall
remain in full force and effect in all respects notwithstanding such discovery, and in accordance with the irrevocable waiver and relinquishment of provisions of California Civil Code Section 1542 or otherwise, the Parties expressly accept and
assume the risk of such possible additions to or differences from those facts now known or believed to be true. 
 3.7
Enforceability. The enforceability of this Agreement is conditioned upon each respective Party satisfying its respective obligations hereunder. 
 3.8 Assignment of Released Claims. The Parties hereby covenant that none of the Released Claims has been assigned to any other person, and that no other person has any interest in any of the
Released Claims. In the event any other person asserts any interest with respect to the Released Claims, then the Party breaching this covenant shall indemnify the Party against whom such claim is asserted for any and all damages, costs, and fees.

 3.9 Specific Exclusion. It is expressly understood that the release contained in this Agreement does not
encompass the promises and obligations of the Parties under this Agreement. This Agreement also does not contemplate or include within the release hereunder post-Effective Date intentionally willful, tortious, or criminal acts of either Party, such
acts being expressly excluded from this Agreement. 
 3.10 No Admission of Liability. Notwithstanding the terms
and conditions of this Agreement, execution hereof shall in no manner or form constitute the admission of liability or of responsibility by either Party in respect to the Working Relationship or otherwise. 

  
 3 

 IV 
 TERMINATION RELATED PROVISIONS 
 4.1 Termination By
Mutual Agreement. The Parties hereby agree that Brovarone’s termination of all position with PURE is by mutual agreement of the Parties and is effective 13 August 2013 and that his last day as a member of the Board shall be deemed to be
the 13th day of August, 2013 (the “Separation Date”). 
 4.2 Termination of Positions By Mutual
Agreement. As of the Separation Date and as additional consideration hereunder, any and all positions held by Brovarone in and with PURE have been terminated by the mutual agreement of the Parties. 

4.3 Express Waiver of Any Other Amounts. Brovarone hereby acknowledges that he is not entitled to receive, and will not
claim, any damages, rights, benefits, or compensation other than as expressly set forth in this Agreement. 
 4.4 Return
of Materials. Upon execution of this Agreement and reasonable request of PURE Brovarone shall deliver to PURE, at PURE’s expense, all equipment, notebooks, documents, memoranda, reports, files, samples, books, correspondence, lists,
computer disks and data bases, computer programs and reports, computer software, and all other written, graphic and computer generated or stored records relating to the business of PURE which are or have been in the possession or under the control
of Brovarone. 
 4.5 Additional Information. As additional consideration in exchange for the Separation Payment,
Brovarone agrees to provide additional information concerning PURE upon reasonable request of PURE for no additional charge from the Separation Date up to and until eighteen (18) months thereafter (the “Consulting Period”). It
is the express intention of PURE that Brovarone performs services during the Consulting Period as an independent contractor to PURE. Nothing in this Agreement shall in any way be construed to constitute Brovarone as an agent, employee, or
representative of PURE. Without limiting the generality of the foregoing, Brovarone is not authorized to bind PURE to any liability or obligation or to represent that Brovarone has any such authority. During the Consulting Period, upon the request
of PURE, Brovarone shall be reasonably available to consult with PURE for no more than 1-hour per week, without carryovers. 

V 

CONFIDENTIALITY AND BUSINESS RELATED COVENANTS 
 5.1 Non-Disclosure of Business Information. Brovarone shall not at any time, either directly or indirectly, use, divulge, disclose or communicate to any person, firm, or corporation, in any
manner whatsoever, any confidential information concerning any matters affecting or relating to the business of PURE, including, without limitation, the names, buying habits or practices of any of its customers, its marketing methods and related
data, the names of any of its vendors or suppliers, costs of materials, the prices it obtains or has obtained or at which it sells or has sold its products or services, manufacturing and sales, costs, lists or other written records used in
PURE’s business, compensation paid to employees and other terms of employment, business plans, financial projections and reports, business strategies, internal operating procedures and other confidential business information from which the PURE
might derive an economic or competitive advantage, or any other confidential information of, about or concerning the business of PURE, its manner of operation, or other confidential data of any kind, nature, or description, whether or not labeled
“secret” or “confidential”. The Parties hereby stipulate that as between them, the foregoing matters are important, material, and confidential trade secrets and affect the successful conduct of the PURE’s business and its
goodwill, and that any breach of any term of this paragraph is a material breach of this Agreement. 
 5.2 Trade
Secrets. Brovarone shall not at any time, either directly or indirectly, use, divulge, disclose or communicate to any person, firm, or corporation, in any manner whatsoever, any of PURE’s trade secrets, including without
limitation, confidential information; customer lists; information concerning current or any future 

  
 4 

 
and proposed work, services or products; the fact that any such work, services or products are planned, under consideration, or in production, as well as any description thereof, computer
programs or computer software. Brovarone agrees that these restrictions shall also apply to (i) trade secrets belonging to third parties in the possession of PURE; and, (ii) trade secrets conceived, originated, discovered, or
developed by PURE during the term of his relationship with PURE. 
 5.3 Competition Covenant. Brovarone hereby
agrees that during and throughout the forty-eight (48) months immediately following the Separation Date he shall not: 
 (a)
Directly or indirectly, in an individual or representative capacity, own an interest in, operate, join, control, finance (whether as a lender or investor), share in the earnings of, participate in, engage in or be connected as an officer, employee,
agent, independent contractor, partner, shareholder, member, consultant, employer, investor, or principal of any corporation, partnership, proprietorship, firm, association, person, or any other entity engaged in any aspect of the business of PURE,
or which is otherwise in competition with PURE, notwithstanding the location of said other business; and 
 (b) Permit his name
to be used, directly or indirectly, by any person, corporation, partnership or other business entity engaged in the business of PURE. 
 5.4 Non-Solicitation of Employees. During and throughout the forty-eight (48) months immediately following the Separation Date Brovarone shall not, directly or indirectly, cause or
induce, or attempt to cause or induce, any employee of PURE to terminate his or her employment with PURE, as such employment exists at any time following the Effective Date. 
 5.5 Non-Solicitation of Business. During and throughout the forty-eight (48) months immediately following the Separation Date Brovarone shall not, directly or indirectly,
(i) solicit business from any customer of PURE, to the extent such business relates to a product or service competitive with an PURE product or service; or, (ii) otherwise attempt to induce any such customer of PURE to cease doing business
with, or to decrease the amount of business such customer does with, PURE. 
 5.6 Mutual Non-Disparagement.
Following the Separation Date: (i) Brovarone will not make or cause to be made any statements or remarks (including, without limitation, the repetition or distribution of disparaging, derogatory or damaging rumors, allegations, negative reports
or comments), whether written, electronic or oral, that are directly or indirectly disparaging, derogatory or damaging to PURE or any of its respective past, current or future affiliates, officers, directors, shareholders, employees, consultants,
advisors, representatives, trustees, subsidiaries, divisions, parent companies, clients or customers or their policies and procedures, business, practices or financial condition; and, (ii) PURE will not make or cause to be made any statements
or remarks (including, without limitation, the repetition or distribution of disparaging, derogatory or damaging rumors, allegations, negative reports or comments), whether written, electronic or oral, that are directly or indirectly disparaging,
derogatory or damaging to Brovarone. However, the foregoing restrictions shall not apply to any statements by Brovarone or by PURE that are made truthfully in response to a subpoena or as otherwise required by applicable law or other
compulsory legal process, or those made in the context of a confidential professional relationship such as between the Parties and legal counsel, accountants and/or financial advisors. 

VI 

ADDITIONAL REPRESENTATIONS AND OBLIGATIONS 
 6.1 Consideration Period. This Agreement has been delivered to Brovarone on the 11th day of August, 2013. Pursuant to law, Brovarone has twenty-one (21) days to consider this Agreement.
Pursuant to Section 6.3, below, Brovarone has been encouraged to seek legal counsel to consider and review this Agreement and based on said review is waiving entitlement to said twenty-one day Consideration Period. 

  
 5 

 6.2 Revocation Period. Upon execution of this Agreement, Brovarone shall have
seven (7) days to revoke the Agreement. Any such revocation by Brovarone must be in writing and delivered to PURE pursuant to the notice requirements of this Agreement. If timely revoked by Brovarone, this Agreement will not be effective or
enforceable, and all Parties shall be immediately released of all obligations hereunder, with no effect on any of the claims each Party may otherwise possess. 
 6.3 Independent Legal Counsel. The Parties to this Agreement warrant, represent, and agree that in executing this Agreement, they do so with full knowledge of the rights each may have with
respect to the other Party, and that each has received, or has had the opportunity to receive, independent legal advice as to these rights. Each of the Parties has executed this Agreement with full knowledge of these rights, and under no fraud,
duress, or undue influence. 
 6.4 Waiver of Age Discrimination Claim. Brovarone understands that the release
contained in this Agreement had to meet certain requirements to constitute a valid release of any claims under the Age Discrimination in Employment Act (“ADEA”), and Brovarone hereby represents that all such requirements were in fact
satisfied. These requirements required the following, each of which has in fact been satisfied: (i) execution of this Agreement by Brovarone has been knowing and voluntary, and free from duress, coercion and mistake of fact; (ii) this
Agreement is in writing and is understandable; (iii) this Agreement has waived current ADEA claims explicitly; (iv) this Agreement has not waived future ADEA claims; (v) the release by Brovarone hereunder of ADEA claims has been paid
for with something to which Brovarone was not already entitled; (vi) this Agreement has advised Brovarone to consult an attorney; (vii) this Agreement has given Brovarone twenty-one (21) days to consider the ADEA release contained in
this Agreement; and, (viii) this Agreement has given Brovarone seven (7) days within which to revoke the ADEA release contained in this Agreement after execution. 
 6.5 Execution and Effect of Agreement. 
 6.5.1. By
PURE. PURE hereby warrants and represents to Brovarone the following: 
 (a) It has the requisite power and authority to
enter into and carry out the terms and conditions of this Agreement, as well as all transactions contemplated hereunder. All proceedings have been taken and all authorizations have been secured which are necessary to authorize the execution,
delivery, and performance by PURE of this Agreement. This Agreement has been duly and validly executed and delivered by PURE and constitutes the valid and binding obligations of PURE, enforceable in accordance with the respective terms. 

(b) The consummation by PURE of the transactions herein contemplated, including the execution, delivery and consummation of this
Agreement, will not violate any judgment, law, order, writ, rule or regulation, or determination or decree of any arbitrator, court, or other governmental agency or administrative body (collectively, “Requirement of Law”) applicable or
binding upon PURE. 
 6.5.2. By Brovarone. Brovarone hereby warrants and represents to PURE the following:

 (a) He has the requisite power and authority to enter into and carry out the terms and conditions of this Agreement, as well
as all transactions contemplated hereunder. All proceedings have been taken and all authorizations have been secured which are necessary to authorize the execution, delivery, and performance by Brovarone of this Agreement. This Agreement has been
duly and validly executed and delivered by Brovarone and constitutes the valid and binding obligations of Brovarone, enforceable in accordance with the respective terms. 
 (b) The consummation by Brovarone of the transactions herein contemplated, including the execution, delivery, and consummation of this Agreement, will not violate any Requirement of Law applicable or
binding upon Brovarone. 

  
 6 

 6.6 Investment Representations. Brovarone is an “accredited
investor”, as that term is defined under Rule 501(a) of Regulation D under the Securities Act of 1933. Brovarone shall execute and deliver all documentation prepared and reasonably requested by PURE in order to confirm Brovarone’s status
as an accredited investor. 
 6.7 No Cooperation. Brovarone will not act in any manner that might damage the
business of PURE. Brovarone will not counsel or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against PURE and/or any officer,
director, employee, agent, representative, shareholder or attorney of PURE, unless under a subpoena or other court order to do so or upon the express written consent of PURE. Brovarone further agrees both to immediately notify PURE upon receipt of
any court order, subpoena, or any legal discovery device that seeks or might require the disclosure or production of the existence or terms of this Agreement, and to furnish, within two (2) business days of its receipt, a copy of such subpoena
or legal discovery device to PURE. 
 6.8 Expenses. Each Party shall pay the fees and expenses of such
Party’s advisers, counsel, accountants, and other experts, if any, and all other expenses incurred by such Party incident to the negotiation, preparation, execution, delivery and performance of this Agreement, and shall hold the other Party
hereto harmless against, any liability, loss or expense (including, without limitation, reasonable attorneys’ fees and out-of-pocket expenses) arising in connection with any claim for such fees and expenses. 

6.9 Tax Liability. Brovarone represents and warrants that neither PURE nor its attorneys nor anyone affiliated with PURE
has made any representations regarding the taxability of the payments and issuance of stock hereunder and that Brovarone has not relied upon any such representation in entering into this Agreement. Brovarone further represents and warrants that he
shall be solely responsible for the payment of any and all federal, state and local taxes which may become due, if any, as a result of the payments and issuance of stock hereunder. Brovarone shall hold PURE harmless from and indemnify it for the
payment of any taxes (including interest) or penalties, and any costs or attorneys’ fees related to such payment, if any, that may be asserted against it by any government agency at any time as a result of the payments or issuance of stock
hereunder. 
 6.10 Death or Disability. In the event of Brovarone’s death or Complete Disability, PURE will
continue all commitments under this Agreement, including but not limited to payments to Brovarone, his estate, successors, or assigns. The term Complete Disability shall mean the inability of Brovarone to perform his duties under this Agreement by
reason of any incapacity, physical or mental, based upon medical advice or an opinion provided by two licensed physicians acceptable to PURE, determines to have incapacitated Brovarone from satisfactorily performing his usual services for PURE under
this Agreement. 
 6.11 Directors and Officers Insurance. For a period of five (5) years commencing with the
Separation Date, PURE shall continue to maintain directors and officers insurance coverage on terms no less favorable than those in place on the Separation Date. If for any reason PURE determines to discontinue such coverage within said five year
period, Brovarone shall be provided advanced written notice of that event. 
 VII 

INTENDED TAX RESULTS 
 7.1 Excise Tax. The Parties believe that the payments and issuance under this Agreement do not constitute “excess parachute payments” under Section 280G of the Internal
Revenue Code of 1986, as amended (the “Code”), or any successor provision. Notwithstanding such belief and intent, if any payment or benefit due under this Agreement, together with all other payments and benefits (including, without
limitation, equity-based compensation awards) to which Brovarone is entitled from PURE, would (if paid or provided) constitute an “excess parachute payment”, the amounts otherwise payable and benefits otherwise due under this Agreement
will either (i) be delivered in full, or (ii) be limited to the minimum extent necessary to ensure that no portion 

  
 7 

 
thereof will fail to be tax-deductible to PURE by reason of Section 280G of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state or local income
and employment taxes and the excise tax imposed under Section 4999 of the Code, results in Brovarone’s receipt, on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be
subject to the excise tax imposed under Section 4999 of the Code. In the event that the payments and/or benefits are to be reduced pursuant to this Section 7.1, such payments and benefits shall be reduced such that the reduction of
compensation to be provided to Brovarone as a result of this Section 7.1 is minimized. In applying this principle, the reduction shall be made in a manner consistent with the requirements of Section 409A of the Code and where two
economically equivalent amounts are subject to reduction but payable at different times, such amounts shall be reduced on a pro rata basis but not below zero. 
 7.2 Compliance with Section 409A. 
 7.2.1.
Intent. The intent of the Parties is that payments and benefits under this Agreement comply with Section 409A of the Code and the regulations and guidance promulgated thereunder (collectively “Section 409A”).
Accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. If Brovarone notifies PURE (with reasonable specificity as to the reason therefor) that Brovarone believes that any provision of this
Agreement (or of any award of compensation, including equity compensation or benefits) would cause Brovarone to incur any additional tax or interest under Section 409A and PURE concurs with such belief or PURE (without any obligation whatsoever
to do so) independently makes such determination, PURE shall, after consulting with Brovarone, reform such provision to attempt to comply with Section 409A through good faith modifications to the minimum extent reasonably appropriate to conform
with Section 409A. To the extent that any provision hereof is modified in order to comply with Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent
and economic benefit/burden to Brovarone and PURE of the applicable provision without violating the provisions of Section 409A. 
 7.2.2. Specific Provisions. A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or
benefits upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A and, for purposes of any such provision of this Agreement, references to a
“termination,” “termination of employment” or like terms shall mean “separation from service”. If Brovarone is deemed on the date of termination to be a “specified employee” within the meaning of that term
under Section 409A(a)(2)(B) of the Code, then with regard to any payment or the provision of any benefit that is specified as subject to this Section or that is otherwise considered deferred compensation under Section 409A payable on
account of a “separation from service,” and that is not exempt from Section 409A as involuntary separation pay or a short-term deferral (or otherwise), such payment or benefit shall be made or provided at the date which is the earlier
of (i) the expiration of the six (6)-month period measured from the date of such “separation from service” of Brovarone, and (ii) the date of Brovarone’s death (the “Delay Period”). Upon the expiration of the Delay
Period, all payments and benefits delayed pursuant to this Section 7.2.2. (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to Brovarone in a lump sum
without interest, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein. 

7.2.3. Reimbursement. With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind
benefits, except as permitted by Section 409A, (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (ii) the amount of expenses eligible for reimbursement, or in-kind
benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, provided that the foregoing clause (ii) shall not be violated without regard to
expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the 

  
 8 

 
arrangement is in effect and (iii) such payments shall be made on or before the last day of Brovarone’s taxable year following the taxable year in which the expense occurred.

 7.2.4. Date of Payment. Whenever a payment under this Agreement specifies a payment period with reference to a
number of days, the actual date of payment within the specified period shall be within the sole discretion of PURE. 
 VIII

 ADDITIONAL PROVISIONS 
 8.1 Executed Counterparts. This Agreement may be executed in any number of counterparts, all of which when taken together shall be considered one and the same agreement, it being understood
that all Parties need not sign the same counterpart. In the event that any signature is delivered by fax or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the Party executing
(or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof. Each of the Parties hereby expressly forever waives any and all rights to raise the use
of a fax machine or E-Mail to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a fax machine or E-Mail, as a defense to the formation of a contract. 

8.2 Successors and Assigns. Except as expressly provided in this Agreement, each and all of the covenants, terms,
provisions, conditions and agreements herein contained shall be binding upon and shall inure to the benefit of the successors and assigns of the Parties hereto. 
 8.3 Article and Section Headings. The article and section headings used in this Agreement are inserted for convenience and identification only and are not to be used in any manner to
interpret this Agreement. 
 8.4 Severability. Each and every provision of this Agreement is severable and
independent of any other term or provision of this Agreement. If any term or provision hereof is held void or invalid for any reason by a court of competent jurisdiction, such invalidity shall not affect the remainder of this Agreement. Similarly,
the obligations of the Parties shall remain in full force and effect in the event any of the intended tax results hereunder shall be denied or otherwise become unavailable. 
 8.5 Governing Law. This Agreement shall be governed by the laws of the State of California, without giving effect to any choice or conflict of law provision or rule (whether of the State of
California or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of California. If any court action is necessary to interpret and or enforce the terms and conditions of this Agreement, the
Parties hereby agree that the Superior Court of California, San Diego, shall be the sole jurisdiction and venue for the bringing of such action. 
 8.6 Entire Agreement. This Agreement, and all references, documents, or instruments referred to herein, contains the entire agreement and understanding of the Parties hereto in respect to
the subject matter contained herein. The Parties have expressly not relied upon any promises, representations, warranties, agreements, covenants, or undertakings, other than those expressly set forth or referred to herein. This Agreement supersedes
any and all prior written or oral agreements, understandings, and negotiations between the Parties with respect to the subject matter contained herein. 
 8.7 Additional Documentation. The Parties hereto agree to execute, acknowledge, and cause to be filed and recorded, if necessary, any and all documents, amendments, notices, and certificates
which may be necessary or convenient under the laws of the State of California. 

  
 9 

 8.8 Attorney’s Fees. If any legal action (including arbitration) is
necessary to interpret and or enforce the terms and conditions of this Agreement, the prevailing Party shall be entitled to costs and reasonable attorney’s fees. 
 8.9 Amendment. This Agreement may be amended or modified only by a writing signed by all Parties. 
 8.10 Remedies. 
 8.10.1. Specific Performance. The
Parties hereby declare that it is impossible to measure in money the damages which will result from a failure to perform any of the obligations under this Agreement. Therefore, each Party waives the claim or defense that an adequate remedy at law
exists in any action or proceeding brought to enforce the provisions hereof. 
 8.10.2. Cumulative. The remedies
of the Parties under this Agreement are cumulative and shall not exclude any other remedies to which any person may be lawfully entitled. 
 8.11 Waiver. No failure by any Party to insist on the strict performance of any covenant, duty, agreement, or condition of this Agreement or to exercise any right or remedy on a breach shall
constitute a waiver of any such breach or of any other covenant, duty, agreement, or condition. 
 8.12
Assignability. This Agreement is not assignable by either Party without the expressed written consent of all Parties. 
 8.13 Notices. 
 8.13.1. Method and Delivery. All
notices, requests and demands hereunder shall be in writing and delivered by hand, by registered or certified mail, or by recognized commercial over-night delivery service (such as Federal Express, UPS, or DHL), and shall be deemed given (a) if
by hand delivery, upon such delivery; (b) if by mail, upon delivery of registered or certified mail, postage prepaid; (c) if by recognized commercial over-night delivery service, upon such delivery. 

8.13.2 Addresses for Notice. 
 If to PURE: 
 Attn: Chairman of the Board, Chief Executive Officer and Chief
Financial Officer 
 1725 Gillespie Way 
 El Cajon, CA 92020 
 If to Brovarone: 

35 Pinyon Pine Road 
 Littleton, CO 80127 
 8.14 Time. All Parties agree that time is of
the essence as to this Agreement. 
 8.15 Provision Not Construed Against Party Drafting Agreement. This Agreement
is the result of negotiations by and between the Parties, and each Party has had the opportunity to be represented by independent legal counsel of its choice. This Agreement is the product of the work and efforts of all Parties, and shall be deemed
to have been drafted by all Parties. In the event of a dispute, no Party hereto shall be entitled to claim that any provision should be construed against any other Party by reason of the fact that it was drafted by one particular Party. 

  
 10 

 8.16 Incorporation of Exhibits and Schedules. The Exhibits and Schedules
identified in this Agreement are incorporated herein by reference and made a part hereof as if set out in full herein. 
 8.17
Recitals. The facts recited in Article II, above, are hereby conclusively presumed to be true as between and affecting the Parties. 
 8.18 Definitional Provisions. For purposes of this Agreement, (i) those words, names, or terms which are specifically defined herein shall have the meaning specifically ascribed to
them; (ii) wherever from the context it appears appropriate, each term stated either in the singular or plural shall include the singular and plural; (iii) wherever from the context it appears appropriate, the masculine, feminine, or
neuter gender, shall each include the others; (iv) the words “hereof”, “herein”, “hereunder”, and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole, and not to any
particular provision of this Agreement; (v) all references to designated “Articles”, “Sections”, and to other subdivisions are to the designated Articles, Sections, and other subdivisions of this Agreement as originally
executed; (vi) all references to “Dollars” or “$” shall be construed as being United States dollars; (vii) the term “including” is not limiting and means “including without limitation”; and,
(viii) all references to all statutes, statutory provisions, regulations, or similar administrative provisions shall be construed as a reference to such statute, statutory provision, regulation, or similar administrative provision as in force
at the date of this Agreement and as may be subsequently amended. 
 VIII 

EXECUTION 
 IN WITNESS WHEREOF, this SETTLEMENT AND RELEASE AGREEMENT has been duly executed by the Parties in San Diego, California, and shall be effective as of and on the Effective Date set forth in Article
I of this Agreement. Each of the undersigned Parties hereby represents and warrants that it (i) has the requisite power and authority to enter into and carry out the terms and conditions of this Agreement, as well as all transactions
contemplated hereunder; and, (ii) it is duly authorized and empowered to execute and deliver this Agreement. 
 THE PARTIES HAVE
CAREFULLY READ THIS ENTIRE AGREEMENT. ITS CONTENTS AND THE RELEASE CONTAINED HEREIN HAVE BEEN FULLY EXPLAINED TO THEM BY THEIR ATTORNEYS, OR THEY HAVE VOLUNTARILY ELECTED NOT TO SEEK THE ADVICE OF AN ATTORNEY. THE PARTIES FULLY UNDERSTAND THE FINAL
AND BINDING EFFECT OF THIS AGREEMENT. THE ONLY PROMISES OR REPRESENTATIONS MADE TO EACH OF THE PARTIES ABOUT THIS AGREEMENT, OR TO INDUCE THEM TO SIGN THIS AGREEMENT, ARE CONTAINED IN THIS AGREEMENT. THE PARTIES ARE SIGNING THIS AGREEMENT KNOWINGLY
AND VOLUNTARILY. 
  

							
		  		  	
	BROVARONE:	  		  	PURE:
			
		  		  	 PURE BIOSCIENCE, INC.,
 a Delaware corporation

				
	/s/ Dennis Brovarone	  		  	BY:	 	/s/ Dennis Atchley
	DENNIS BROVARONE	  		  	NAME:	 	Dennis Atchley
		  		  	TITLE:	 	Secretary
			
	DATED: 13 August 2013	  		  	DATED: 13 August 2013
		  		  		 	
		  		  	
		  		  		 	
		  		  		 	
		  		  		 	

  
 11EX-10.1

 Exhibit 10.1 

COMMERCIAL VEHICLE GROUP, INC. 
 EMPLOYMENT AGREEMENT 
 EMPLOYMENT AGREEMENT (this
“Agreement”) dated as of August 14, 2013 between Commercial Vehicle Group, Inc., a Delaware corporation (the “Company”), and Richard P. Lavin (the “Executive”). 

W I T N E S S E T H 
 WHEREAS, the Company desires to employ the Executive as the President and Chief Executive Officer of the Company; and 
 WHEREAS, the Company and the Executive desire to enter into this Agreement as to the terms of the Executive’s employment with the Company. 

NOW, THEREFORE, in consideration of the foregoing, of the mutual promises contained herein and of other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 

1. POSITION AND DUTIES. 
 (a) During the Employment Term (as defined in Section 2 hereof), the Executive shall serve as the President and Chief Executive Officer of the Company. In this capacity, the Executive shall
have the duties, authorities and responsibilities as may reasonably be assigned to the Executive by the Board of Directors of the Company (the “Board”) that are not inconsistent with the Executive’s position as President and
Chief Executive Officer of the Company. The Executive’s principal place of employment with the Company shall be in New Albany, Ohio provided that the Executive understands and agrees that the Executive may be required to travel from time
to time for business purposes. The Executive shall report directly to the Board. 
 (b) During the Employment Term, the Executive
shall devote all of the Executive’s business time, energy, business judgment, knowledge and skill and the Executive’s best efforts to the performance of the Executive’s duties with the Company, provided that the foregoing shall
not prevent the Executive from (i) serving on the boards of directors of non-profit organizations and, with the prior written approval of the Board, other for profit companies, (ii) participating in charitable, civic, educational,
professional, community or industry affairs, and (iii) managing the Executive’s passive personal investments so long as such activities in the aggregate do not interfere or conflict with the Executive’s duties hereunder or create a
potential business or fiduciary conflict. Executive presently serves on the board of directors of two for profit companies, and the Company approves such continuing service, so long as such service does not create a business or fiduciary conflict.

  

 (c) The Board shall take such action as may be necessary to appoint or elect the Executive
as a member of the Board as of the Effective Date (as defined in Section 2 hereof). Thereafter, during the Employment Term, the Board shall nominate the Executive for re-election as a member of the Board at the expiration of the then
current term, provided that the foregoing shall not be required to the extent prohibited by legal or regulatory requirements. 
 2. EMPLOYMENT TERM. The Company agrees to employ the Executive pursuant to the terms of this Agreement, and the Executive agrees to be so employed, for a term of three years (the “Initial
Term”) commencing as of the date hereof (the “Effective Date”). On each anniversary of the Effective Date following the Initial Term, the term of the Agreement shall be automatically extended for successive one-year
periods, provided, however, that either party hereto may elect not to extend this Agreement by giving written notice to the other party at least ninety (90) days prior to any such anniversary date. Notwithstanding the foregoing,
the Executive’s employment hereunder may be earlier terminated in accordance with Section 8 hereof, subject to Section 9 hereof. The period of time between the Effective Date and the termination of the Executive’s
employment hereunder shall be referred to herein as the “Employment Term.” For the avoidance of doubt, following the Employment Term the Executive shall continue to be subject to the Restrictive Covenants (as defined in
Section 11), in each case in accordance with their terms. 
 3. BASE SALARY. The Company agrees to pay
the Executive a base salary at an annual rate of not less than $750,000, payable in accordance with the regular payroll practices of the Company, but not less frequently than monthly. The Executive’s Base Salary shall be subject to annual
review by the Board (or a committee thereof). The base salary as determined herein and as may be adjusted upward from time to time shall constitute “Base Salary” for purposes of this Agreement. 

4. SIGNING BONUS. Upon the Effective Date, the Executive shall be paid a one-time signing bonus in the amount of $325,000. Should
the Executive voluntarily terminate his employment with the Company for any reason other than for Good Reason (as defined in Section 8(e) below), or should the Executive be terminated by the Company for Cause (as defined in
Section 8(c) below, in each case within 24 months following the Effective Date (the “Recovery Period”), the signing bonus payment is subject to recovery by the Company at a rate of 1/24 per month for each month
remaining in the Recovery Period at the time of termination of employment. 
 5. ANNUAL BONUS. During the
Employment Term, the Executive shall be eligible to receive an annual discretionary incentive payment under the Company’s annual bonus plan as may be in effect from time to time (the “Annual Bonus”) based on a target bonus
opportunity of at least 100% of the Executive’s Base Salary (the “Target Bonus”), upon the attainment of one or more pre-established performance goals established by the Board or the Company’s Compensation Committee (the
“Committee”) in its sole discretion. The Annual Bonus shall be paid in accordance with the written terms of the bonus plan as may be adopted from time to time by the Board or Committee. Any Annual Bonus received by the Executive for
the 2013 bonus plan year shall be pro-rated based on the portion of such bonus period that includes the Employment Term. Any Annual Bonus earned hereunder shall be paid no later than March 15th of the calendar year following the calendar year
in which or with which the applicable annual bonus period ends. 

  
 2 

 6. EQUITY INCENTIVE AWARDS. The Executive shall be considered to receive equity and
other long-term incentive awards under any applicable plan adopted by the Company during the Employment Term for which employees are generally eligible. The level of the Executive’s participation in any such plan, if any, shall be determined in
the sole discretion of the Board from time to time. 
 (a) RESTRICTED STOCK. The Executive shall be granted,
within 30 days of the Effective Date, an award of 100,000 shares of restricted stock pursuant to the terms of the Company’s Equity Incentive Plan. Such restricted stock will vest ratably over a period of three years. The terms and conditions of
the award shall be governed in all respects by the definitive documentation related to the grant of such award. 

(b) LONG TERM INCENTIVE AWARDS. Executive shall be eligible, pursuant to the terms of the Company’s long-term incentive
plan, to receive additional discretionary annual incentive awards equal to $750,000 at target, with 50% of such award being issued in time-based shares of restricted stock which vest ratably over a period of three years and 50% of such award being a
cash-based, performance driven award based on relative total shareholder return versus a peer group. The terms and conditions of such awards shall be no less favorable than those awards granted to other senior executive officers of the Company. 

 7. EMPLOYEE BENEFITS. 
 (a) BENEFIT PLANS. During the Employment Term, the Executive shall be entitled to participate in any employee benefit plan that the Company has adopted or may adopt, maintain or contribute
to for the benefit of its employees generally, subject to satisfying the applicable eligibility requirements, except to the extent such plans are duplicative of the benefits otherwise provided to hereunder. Such benefit plans include, for the
avoidance of doubt, the Commercial Vehicle Group, Inc. Deferred Compensation Plan. The Executive’s participation will be subject to the terms of the applicable plan documents and generally applicable Company policies. Notwithstanding the
foregoing, the Company may modify or terminate any employee benefit plan at any time.  
 (b) VACATIONS.
During the Employment Term, the Executive shall be entitled to four (4) weeks of paid vacation per calendar year (as prorated for partial years) in accordance with the Company’s policy on accrual and use applicable to employees as in
effect from time to time. Vacation may be taken at such times and intervals as the Executive determines, subject to the business needs of the Company.  
 (c) BUSINESS EXPENSES. Upon presentation of reasonable substantiation and documentation as the Company may specify from time to time, the Executive shall be reimbursed in accordance with the
Company’s expense reimbursement policy, for all reasonable out-of-pocket business expenses incurred and paid by the Executive during the Employment Term and in connection with the performance of the Executive’s duties hereunder. 

  
 3 

 (d) RELOCATION. The Executive shall promptly relocate to the vicinity of the
Company’s current headquarters. The Executive shall be entitled to relocation benefits of up to $200,000, in accordance with the Company’s relocation program as in effect from time to time, which relocation services are provided by SIRVA
on behalf of the Company. Costs incurred in excess of this amount will be considered, but require specific review and approval by the Board. All amounts payable under this Section 7(d) shall be reimbursed only to the extent incurred
during the first twelve (12) months of the Employment Term and subject to the Executive’s presentment to the Company of appropriate documentation and shall be subject to the limitations and procedures set forth in the Company’s
relocation program as in effect from time to time.  
 (e) STOCK OWNERSHIP REQUIREMENT. Pursuant to the
Company’s Stock Ownership Guidelines (as of March 7, 2011) (the “Stock Ownership Policy”), the President and Chief Executive Officer is expected to own and hold shares of the Company’s common stock with a Value (as
defined in the Stock Ownership Policy) equal to three times the annual Base Salary of the President and Chief Executive Officer. Executive shall have three years from the Effective Date to achieve the required stock ownership under the Stock
Ownership Policy. Nothing in this Agreement shall be construed as modifying the terms of the Stock Ownership Policy, which shall be binding on the Executive.  
 8. TERMINATION. The Executive’s employment and the Employment Term shall terminate on the first of the following to occur:  

(a) DISABILITY. The Company will be entitled to terminate the Executive’s employment because of his disability upon 30 days
written notice. “Disability” will mean “total disability” as defined in the Company’s long term disability plan or any successor thereto. 
 (b) DEATH. Automatically upon the date of death of the Executive. 

(c) CAUSE. Immediately upon written notice by the Company to the Executive of a termination for Cause. As used in this
Agreement, the term “Cause” shall refer only to any one or more of the following grounds:  
  

	 	(i)	Commission of a willful act of dishonesty involving the Company, its business or property, including, but not limited to, misappropriation of funds or any property of
the Company; 

  

	 	(ii)	Willful engagement in activities or conduct clearly injurious to the best interests or reputation of the Company; 

 

	 	(iii)	Willful and continued failure substantially to perform his duties under this Agreement (other than as a result of physical or mental illness or injury), after the Board
of Directors of the Company delivers to Executive a written demand for substantial performance that specifically identifies the manner in which the Board believes that he has not substantially performed his duties; 

 

	 	(iv)	Illegal conduct or gross misconduct that is willful and results in material and demonstrable damage to the business or reputation of the Company;

  
 4 

	 	(v)	The clear and willful violation of any of the material terms and conditions of this Agreement or any other written agreement or agreements Executive may from time to
time have with the Company; 

  

	 	(vi)	The clear and willful violation of the Company’s code of business conduct or the clear and willful violation of any other material rules of behavior as may be
provided in any employee handbook which would be grounds for dismissal of any employee of the Company; or 

  

	 	(vii)	Commission of a crime which is a felony, a misdemeanor involving an act of moral turpitude, or a misdemeanor committed in connection with his employment by the Company
which causes the Company a substantial detriment. 

 No act or failure to act shall be considered
“willful” unless it is done, or omitted to be done, by Executive in bad faith or without reasonable belief that his action or omission was in the best interests of the Company. Any act or failure to act that is based upon authority given
pursuant to a resolution duly adopted by the Board of Directors, or the advice of counsel for the Company, shall be conclusively presumed to be done, or omitted to be done, by Executive in good faith and in the best interests of the Company.

 Following a termination for Cause by the Company, if Executive desires to contest such determination,
Executive’s sole remedy will be to submit the Company’s determination of Cause to arbitration in Columbus, Ohio before a single arbitrator under the commercial arbitration rules of the American Arbitration Association. If the arbitrator
determines that the termination was other than for Cause, the Company’s sole liability to Executive will be the amount that would be payable to Executive under Section 9 of this Agreement for a termination of Executive’s
employment by the Company without Cause. Each party will bear his or its own expenses of the arbitration. 
 (d)
WITHOUT CAUSE. Immediately upon written notice by the Company to the Executive of an involuntary termination without Cause (other than for death or Disability).  
 (e) GOOD REASON. Upon written notice by the Executive to the Company of a termination for Good Reason. “Good Reason” shall mean, without Executive’s written consent:
 
  

	 	(i)	a material change in Executive’s status, position or responsibilities which, in his reasonable judgment, does not represent a promotion from his existing status,
position or responsibilities as in effect immediately prior to the Change in Control; or the assignment of any duties or responsibilities or the removal or termination of duties or responsibilities (except in connection with the termination of
employment for total and permanent Disability, Death, or Cause, or by Executive other than for Good Reason), which, in his reasonable judgment, are materially inconsistent with such status, position or responsibilities; 

  
 5 

	 	(ii)	a reduction by the Company in Executive’s Base Salary as in effect on the date hereof or as the same may be increased from time to time during the term of this
Agreement; or the Company’s failure to increase (within twelve months of his last increase in Base Salary) Executive’s Base Salary after a Change in Control in an amount which at least equals, on a percentage basis, the average percentage
increase in Base Salary for all executive and senior officers of the Company, in like positions, which were effected in the preceding twelve months; 

  

	 	(iii)	the relocation of the Company’s principal executive offices to a location outside the greater Columbus metropolitan area; or the relocation of Executive by the
Company to any place other than the location at which Executive performed duties prior to a Change in Control, except for required travel on the Company’s business to an extent consistent with business travel obligations at the time of a Change
in Control; 

  

	 	(iv)	the failure of the Company to continue in effect, or continue or materially reduce Executive’s participation in, any incentive, bonus or other compensation plan in
which Executive participates, including but not limited to the Company’s stock option plans, unless an equitable arrangement (embodied in an ongoing substitute or alternative plan), has been made or offered with respect to such plan;

  

	 	(v)	the failure by the Company to continue to provide Executive with benefits substantially similar to those enjoyed or to which Executive is entitled under any of the
Company’s deferred compensation, pension, profit sharing, life insurance, medical, dental, health and accident, or disability plans, the taking of any action by the Company which would directly or indirectly materially reduce any of such
benefits or deprive Executive of any material fringe benefit enjoyed or to which Executive is entitled at the time of such action, or the failure by the Company to provide the number of paid vacation and sick leave days to which Executive is
entitled on the basis of years of service with the Company in accordance with the Company’s normal vacation policy in effect on the date hereof; 

  

	 	(vi)	the failure of the Company to obtain a satisfactory agreement from any successor or assign of the Company to assume and agree to perform this Agreement;

  

	 	(vii)	any request by the Company that Executive participate in an unlawful act or take any action constituting a breach of Executive’s professional standard of conduct;
or 

  

	 	(viii)	any breach of this Agreement on the part of the Company. 

 Notwithstanding anything in this Section to the contrary, Executive’s right to terminate his employment pursuant to this Section shall not be affected by incapacity due to physical or mental illness.

  
 6 

 9. CONSEQUENCES OF TERMINATION. 

(a) DEATH OR DISABILITY. In the event that the Executive’s employment and/or Employment Term ends on account of the
Executive’s Death or Disability, the Company shall pay or provide the Executive (i) the earned but unpaid portion of Executive’s Base Salary through the employment termination date; (ii) reimbursement of all business expenses for
which Executive is entitled to be reimbursed pursuant to Section 7(c) above, but for which Executive has not yet been reimbursed; (iii) vested benefits, if any, to which Executive may be entitled under the Company’s employee
benefit plans as of the employment termination date; (iv) any Annual Bonus earned with respect to the previous calendar year but unpaid as of the employment termination date; and (v) a prorated amount of the Annual Bonus for the calendar
year in which the termination occurs, calculated by multiplying the Annual Bonus that Executive would have received for such year had Executive’s employment continued through the end of such calendar year by a fraction, the numerator of which
is the number of days the Executive was employed during the applicable year and the denominator of which is 365. 
 (b)
TERMINATION FOR CAUSE OR BY EXECUTIVE WITHOUT GOOD REASON. If the Executive’s employment is terminated (x) by the Company for Cause or (y) by the Executive for any reason other than for Good Reason, the Company shall pay or
provide Executive (i) the earned but unpaid portion of Executive’s Base Salary through the employment termination date; (ii) reimbursement of all business expenses for which Executive is entitled to be reimbursed pursuant to
Section 7(c) above, but for which Executive has not yet been reimbursed; and (iii) vested benefits, if any, to which Executive may be entitled under the Company’s employee benefit plans as of the termination. 

(c) TERMINATION BY COMPANY WITHOUT CAUSE OR TERMINATION BY EXECUTIVE FOR GOOD REASON. In the event that Executive’s employment
is terminated (x) by the Company without Cause (and other than due to the Executive’s death or Disability) or (y) by Executive for Good Reason (and either such termination is not within 13 months following a Change in Control), the
Company shall pay or provide Executive (i) the earned but unpaid portion of Executive’s Base Salary through the employment termination date; (ii) reimbursement of all business expenses for which Executive is entitled to be reimbursed
pursuant to Section 7(c) above, but for which Executive has not yet been reimbursed; (iii) vested benefits, if any, to which Executive may be entitled under the Company’s employee benefit plans as of the employment termination
date; (iv) any Annual Bonus earned with respect to the previous calendar year but unpaid as of the employment termination date; (v) a prorated amount of the Annual Bonus for the calendar year in which the termination occurs, calculated by
multiplying the Annual Bonus that Executive would have received for such year had Executive’s employment continued through the end of such calendar year by a fraction, the numerator of which is the number of days the Executive was employed
during the applicable year and the denominator of which is 365; (vi) immediate vesting of all outstanding stock options and restricted stock awards issued to Executive, and thereafter shall be exercisable until the earlier of (A) 12 months
after the Employment termination date or (B) the original expiration date of such stock options (but in no event later than the date at which such options may remain outstanding without subjecting the options to the excise tax under Code
Section 409A, as defined below); (vii) salary continuation severance pay at the Base Salary rate for an additional twenty-four (24) months (the “Severance Period”); provided, however, any such severance payments will
immediately end if (1) Executive is in violation of any of his obligations under this Agreement, including Section 11; or (2) the Company, after Executive’s termination, learns of any facts

  
 7 

 
about his job performance or conduct that would have given the Company Cause, as defined in Section 8(c), to terminate his employment. Any amounts payable pursuant to subparts
(v) and (vii) of this Section 9(c) shall not be paid until the Company’s first scheduled regular payroll date following the date the General Release (as defined below) is executed and no longer subject to revocation, with
the first such payment being in an amount equal to the total amount to which Executive would otherwise have been entitled during the period following the date of termination if such deferral had not been required; provided, however, that any such
amounts that constitute nonqualified deferred compensation within the meaning of Internal Revenue Code Section 409A and the regulations and guidance promulgated thereunder (“Code Section 409A”) shall not be paid until the
60th day following such termination to the extent necessary to avoid adverse tax consequences under Section 409A, and, if such payments are required to be so deferred, the first payment shall be in an amount equal to the total amount to which
Executive would otherwise have been entitled during the period following the date of termination if such deferral had not been required. 
 (d) TERMINATION FOLLOWING CHANGE OF CONTROL. If a Change in Control, as defined in Section 9(d)(v), shall have occurred and within 13 months following such Change in Control the
Company terminates Executive’s employment other than for Cause, as defined in Section 8(c), or Executive terminates his employment for Good Reason, as defined in Section 8(e), then Executive shall be entitled to the
benefits described below:  
  

	 	(i)	Executive shall be entitled to (A) the unpaid portion of his Base Salary plus credit for any vacation accrued but not taken, (B) reimbursement of all business
expenses for which Executive is entitled to be reimbursed pursuant to Section 7(c) above, (C) any Annual Bonus earned with respect to the previous calendar year but unpaid as of the employment termination date, (D) a prorated
amount of the Annual Bonus for the calendar year in which the termination occurs, calculated by multiplying the Annual Bonus that Executive would have received for such year had Executive’s employment continued through the end of such calendar
year by a fraction, the numerator of which is the number of days the Executive was employed during the applicable year and the denominator of which is 365, and (E) the amount of any earned but unpaid portion of any bonus, incentive
compensation, or any other fringe benefit to which Executive is entitled under this Agreement through the date of the termination as a result of a Change in Control (the “Unpaid Earned Compensation”), plus two (2) times
Executive’s Current Annual Compensation as defined in this Section 9(d)(i) (the “Salary Termination Benefit”). For purposes of this Agreement, “Current Annual Compensation” shall mean the total of
Executive’s Base Salary in effect at the employment termination date, plus the average annual performance bonus actually received by Executive over the last three fiscal years (or if Executive has been employed for a shorter period of time over
such period during which Executive performed services for the Company) plus any medical, financial and insurance coverage provided presently under Executive’s current annual compensation plan, and shall not include the value of any stock
options granted or exercised, restricted stock awards granted or vested, contributions to 401(k) or other qualified plans. 

  
 8 

	 	(ii)	Immediate vesting of all outstanding stock options and restricted stock awards issued to Executive, and thereafter shall be exercisable until the earlier of (x) 12
months after the Termination Date or (y) the original expiration date of such stock options (but in no event later than the date at which such options may remain outstanding without subjecting the options to the excise tax under Code
Section 409A). 

  

	 	(iii)	Subject to (A) Executive’s timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
(“COBRA”), (B) Executive’s continued copayment of premiums at the same level and cost to Executive as if Executive were an employee of the Company (excluding, for purposes of calculating cost, an employee’s ability to
pay premiums with pre-tax dollars) continued participation in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan) which covers Executive (and the Employee’s eligible dependents) until
the earlier of (A) 18 months after termination of employment following a Change in Control, or (B) Executive’s commencement of full-time employment with a new employer with comparable benefits; provided Executive’s continued
participation is permitted under the general terms of such plans and programs after the Change in Control (“Fringe Termination Benefit”); (collectively the Salary Termination Benefit and the Fringe Termination Benefit are referred
to as the “Termination Benefits”). The Company may modify its obligation under this Section 9(d)(iii) to the extent necessary to avoid any penalty or excise taxes imposed on the Company in connection with the continued
payment of premiums by the Company under the Patient Protection and Affordable Care Act. 

  

	 	(iv)	 The Unpaid Earned Compensation shall be paid to Executive within 15 days after termination of employment, one-half of the Salary Termination Benefit
shall be payable to Executive as severance pay in a lump sum payment within 30 days after termination of employment, and one-half of the Salary Termination Benefit shall be payable to Executive as severance pay in equal monthly payments commencing
30 days after termination of employment and ending on the date that is the earlier of two and one-half months after the end of the Company’s taxable year in which termination occurred or Executive’s death; provided, however, the Company
may immediately discontinue the payment of the Termination Benefits if (i) Executive is in violation of any of his obligations under this Agreement, including in Section 11; and/or (ii) the Company, after Executive’s
termination, learns of any facts about Executive’s job performance or conduct that would have given the Company Cause as defined in Section 8(c) to terminate his employment. Executive shall have no duty to mitigate his damages by
seeking other employment, and the Company 

  
 9 

	 	
shall not be entitled to set off against amounts payable hereunder any compensation which Executive may receive from future employment. To the extent necessary, the parties hereto agree to
negotiate in good faith should any amendment to this Agreement required in order to comply with Section 409A of the Code, provided, however, no amendment shall be effected after the occurrence of a Change in Control. Any amounts payable
pursuant to this Section 9(d)(iv) shall not be paid until the first scheduled payment date following the date the General Release (as defined below) is executed and no longer subject to revocation, with the first such payment being in an
amount equal to the total amount to which Executive would otherwise have been entitled during the period following the date of termination if such deferral had not been required; provided, however, that any such amounts that constitute nonqualified
deferred compensation within the meaning of Code Section 409A shall not be paid until the 60th day following such termination to the extent necessary to avoid adverse tax consequences under Section 409A, and, if such payments are required
to be so deferred, the first payment shall be in an amount equal to the total amount to which Executive would otherwise have been entitled during the period following the date of termination if such deferral had not been required.

  

	 	(v)	 A “Change in Control” shall be deemed to have occurred if and when, after the date hereof, (i) any “person” (as that
term is used in Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) on the date hereof), including any “group” as such term is used in Section 13(d)(3) of the Exchange
Act on the date hereof, shall acquire (or disclose the previous acquisition of) beneficial ownership (as that term is defined in Section 13(d) of the Exchange Act and the rules thereunder on the date hereof) of shares of the outstanding stock
of any class or classes of the Company which results in such person or group possessing more than 50% of the total voting power of the Company’s outstanding voting securities ordinarily having the right to vote for the election of directors of
the Company; or (ii) as the result of, or in connection with, any tender or exchange offer, merger or other business combination, or contested election, or any combination of the foregoing transactions (a “Transaction”), the
owners of the voting shares of the Company outstanding immediately prior to such Transaction own less than a majority of the voting shares of the Company after the Transaction; or (iii) during any period of two consecutive years during the term
of this Agreement, individuals who at the beginning of such period constitute the Board of Directors of the Company (or who take office following the approval of a majority of the directors then in office who were directors at the beginning of the
period) cease for any reason to constitute at least one-half thereof, unless the election of each director who was not a director at the beginning of such period has been approved in advance by directors of the Company representing at least one-half
of the directors then in office who were directors at the beginning of the period; or (iv) the sale, 

  
 10 

	 	
exchange, transfer, or other disposition of all or substantially all of the assets of the Company (a “Sale Transaction”) shall have occurred. Notwithstanding the foregoing, an
event shall not be treated as a “Change in Control” hereunder unless such event also constitutes a change in the ownership or effective control of a corporation, or a change in the ownership of a substantial portion of the assets of a
corporation pursuant to Code Section 409A. 

 (e) OTHER OBLIGATIONS. Upon any termination of the
Executive’s employment with the Company, the Executive shall promptly resign from the Board and any position as an officer, director or fiduciary of any Company-related entity.  

(f) EXCLUSIVE REMEDY. The amounts payable to the Executive following termination of employment and the Employment Term
hereunder pursuant to Sections 8 and 9 hereof shall be in full and complete satisfaction of the Executive’s rights under this Agreement and any other claims that the Executive may have in respect of the Executive’s employment
with the Company or any of its affiliates, and the Executive acknowledges that such amounts are fair and reasonable, and are the Executive’s sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the
termination of the Executive’s employment hereunder or any breach of this Agreement.  
 10. RELEASE; NO
MITIGATION. Any and all amounts payable and benefits or additional rights provided pursuant to this Agreement beyond the earned but unpaid Base Salary shall only be payable if the Executive delivers to the Company and does not revoke a general
release of claims in favor of the Company (the “General Release”) in the form provided as Exhibit A to this Agreement. The General Release must be executed and delivered (and no longer subject to revocation, if applicable)
within sixty (60) days following termination. Executive shall not be required to mitigate the amount of any payment or benefit provided pursuant to this Agreement by seeking other employment or otherwise, and the Company shall not be entitled
to any offset from any payment or benefit owed to Executive under this Agreement in the event Executive secures other employment. 
 11. RESTRICTIVE COVENANTS. 
 (a) CONFIDENTIALITY. During the course
of the Executive’s employment with the Company, the Executive will have access to Confidential Information. For purposes of this Agreement, “Confidential Information” means all data, information, ideas, concepts, discoveries,
trade secrets, inventions (whether or not patentable or reduced to practice), innovations, improvements, know-how, developments, techniques, methods, processes, treatments, drawings, sketches, specifications, designs, plans, patterns, models, plans
and strategies, and all other confidential or proprietary information or trade secrets in any form or medium (whether merely remembered or embodied in a tangible or intangible form or medium) whether now or hereafter existing, relating to or arising
from the past, current or potential business, activities and/or operations of the Company or any of its affiliates, including, without limitation, any such information relating to or concerning finances, sales, marketing, advertising, transition,
promotions, pricing, personnel, customers, suppliers, vendors, raw partners and/or competitors. The Executive agrees that the Executive shall not, directly or indirectly, use, make available, sell,

  
 11 

 
disclose or otherwise communicate to any person, other than in the course of the Executive’s assigned duties and for the benefit of the Company, either during the period of the
Executive’s employment or at any time thereafter, any Confidential Information or other confidential or proprietary information received from third parties subject to a duty on the Company’s and its subsidiaries’ and affiliates’
part to maintain the confidentiality of such information, and to use such information only for certain limited purposes, in each case, which shall have been obtained by the Executive during the Executive’s employment by the Company (or any
predecessor). The foregoing shall not apply to information that (i) was known to the public prior to its disclosure to the Executive; (ii) becomes generally known to the public subsequent to disclosure to the Executive through no wrongful
act of the Executive or any representative of the Executive; or (iii) the Executive is required to disclose by applicable law, regulation or legal process (provided that the Executive provides the Company with prior notice of the contemplated
disclosure and cooperates with the Company at its expense in seeking a protective order or other appropriate protection of such information). 
 (b) NONCOMPETITION. The Executive acknowledges that (i) the Executive performs services of a unique nature for the Company that are irreplaceable, and that the Executive’s
performance of such services to a competing business will result in irreparable harm to the Company, (ii) the Executive has had and will continue to have access to Confidential Information which, if disclosed, would unfairly and inappropriately
assist in competition against the Company or any of its affiliates, (iii) in the course of the Executive’s employment by a competitor, the Executive would inevitably use or disclose such Confidential Information, (iv) the Company and
its affiliates have substantial relationships with their customers and the Executive has had and will continue to have access to these customers, (v) the Executive has received and will receive specialized training from the Company and its
affiliates, and (vi) the Executive has generated and will continue to generate goodwill for the Company and its affiliates in the course of the Executive’s employment. Accordingly, during the Executive’s employment hereunder and for a
period of two years thereafter, the Executive agrees that the Executive will not, directly or indirectly, own, manage, operate, control, be employed by (whether as an employee, consultant, independent contractor or otherwise, and whether or not for
compensation) or render services to any person, firm, corporation or other entity, in whatever form, engaged in competition with the Company or any of its subsidiaries or affiliates or in any other material business in which the Company or any of
its subsidiaries or affiliates is engaged on the date of termination or in which they have planned, on or prior to such date, to be engaged in on or after such date, in any locale of any country in which the Company conducts business.
Notwithstanding the foregoing, nothing herein shall prohibit the Executive from being a passive owner of not more than one percent (1%) of the equity securities of a publicly traded corporation engaged in a business that is in competition with
the Company or any of its subsidiaries or affiliates, so long as the Executive has no active participation in the business of such corporation.  
 (c) NONSOLICITATION; NONINTERFERENCE. 
  

	 	(i)	 During the Executive’s employment with the Company and for a period of two years thereafter, the Executive agrees that the Executive shall not,
except in the furtherance of the Executive’s duties hereunder, directly or indirectly, individually or on behalf of any other person, firm, corporation or other entity, solicit, aid or induce any customer of the Company or any

  
 12 

	 	
of its subsidiaries or affiliates to purchase goods or services then sold by the Company or any of its subsidiaries or affiliates from another person, firm, corporation or other entity or assist
or aid any other persons or entity in identifying or soliciting any such customer. 

  

	 	(ii)	During the Executive’s employment with the Company and for a period of two years thereafter, the Executive agrees that the Executive shall not, except in the
furtherance of the Executive’s duties hereunder, directly or indirectly, individually or on behalf of any other person, firm, corporation or other entity, (A) solicit, aid or induce any employee, representative or agent of the Company or
any of its subsidiaries or affiliates to leave such employment or retention or to accept employment with or render services to or with any other person, firm, corporation or other entity unaffiliated with the Company or hire or retain any such
employee, representative or agent, or take any action to materially assist or aid any other person, firm, corporation or other entity in identifying, hiring or soliciting any such employee, representative or agent, or (B) interfere, or aid or
induce any other person or entity in interfering, with the relationship between the Company or any of its subsidiaries or affiliates and any of their respective vendors, joint venturers or licensors. An employee, representative or agent shall be
deemed covered by this Section 11(c)(ii) while so employed or retained and for a period of six (6) months thereafter. 

  

	 	(iii)	Notwithstanding the foregoing, the provisions of this Section 11(c) shall not be violated by (A) general advertising or solicitation not specifically
targeted at Company-related persons or entities, (B) the Executive serving as a reference, upon request, for any employee of the Company or any of its subsidiaries or affiliates so long as such reference is not for an entity that is employing
or retaining the Executive, or (C) actions taken by any person or entity with which the Executive is associated if the Executive is not personally involved in any manner in the matter and has not identified such Company-related person or entity
for soliciting or hiring. 

 (d) NONDISPARAGEMENT. The Executive agrees not to make negative comments
or otherwise disparage the Company or its officers, directors, employees, shareholders, agents or products other than in the good faith performance of the Executive’s duties to the Company while the Executive is employed by the Company. The
foregoing shall not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such
proceedings).  
 (e) INVENTIONS. 

 

	 	(i)	 The Executive acknowledges and agrees that all ideas, methods, inventions, discoveries, improvements, work products, developments, software, know-how,
processes, techniques, methods, works of authorship and other work product, whether patentable or unpatentable, (A) that are 

  
 13 

	 	
reduced to practice, created, invented, designed, developed, contributed to, or improved with the use of any Company resources and/or within the scope of the Executive’s work with the
Company or that relate to the business, operations or actual or demonstrably anticipated research or development of the Company, and that are made or conceived by the Executive, solely or jointly with others, during the Employment Term, or
(B) suggested by any work that the Executive performs in connection with the Company, either while performing the Executive’s duties with the Company or on the Executive’s own time, shall belong exclusively to the Company (or its
designee), whether or not patent or other applications for intellectual property protection are filed thereon (the “Inventions”). The Executive will keep full and complete written records (the “Records”), in the
manner prescribed by the Company, of all Inventions, and will promptly disclose all Inventions completely and in writing to the Company. The Records shall be the sole and exclusive property of the Company, and the Executive will surrender them upon
the termination of the Employment Term, or upon the Company’s request. The Executive irrevocably conveys, transfers and assigns to the Company the Inventions and all patents or other intellectual property rights that may issue thereon in any
and all countries, whether during or subsequent to the Employment Term, together with the right to file, in the Executive’s name or in the name of the Company (or its designee), applications for patents and equivalent rights (the
“Applications”). The Executive will, at any time during and subsequent to the Employment Term, make such applications, sign such papers, take all rightful oaths, and perform all other acts as may be requested from time to time by
the Company to perfect, record, enforce, protect, patent or register the Company’s rights in the Inventions, all without additional compensation to the Executive from the Company. The Executive will also execute assignments to the Company (or
its designee) of the Applications, and give the Company and its attorneys all reasonable assistance (including the giving of testimony) to obtain the Inventions for the Company’s benefit, all without additional compensation to the Executive
from the Company. 

  

	 	(ii)	 In addition, the Inventions will be deemed Work for Hire, as such term is defined under the copyright laws of the United States, on behalf of the
Company and the Executive agrees that the Company will be the sole owner of the Inventions, and all underlying rights therein, in all media now known or hereinafter devised, throughout the universe and in perpetuity without any further obligations
to the Executive. If the Inventions, or any portion thereof, are deemed not to be Work for Hire, or the rights in such Inventions do not otherwise automatically vest in the Company, the Executive hereby irrevocably conveys, transfers and assigns to
the Company, all rights, in all media now known or hereinafter devised, throughout the universe and in perpetuity, in and to the Inventions, including, without limitation, all of the Executive’s right, title and interest in the copyrights (and
all renewals, revivals and extensions thereof) to the 

  
 14 

	 	
Inventions, including, without limitation, all rights of any kind or any nature now or hereafter recognized, including, without limitation, the unrestricted right to make modifications,
adaptations and revisions to the Inventions, to exploit and allow others to exploit the Inventions and all rights to sue at law or in equity for any infringement, or other unauthorized use or conduct in derogation of the Inventions, known or
unknown, prior to the date hereof, including, without limitation, the right to receive all proceeds and damages therefrom. In addition, the Executive hereby waives any so-called “moral rights” with respect to the Inventions. To the extent
that the Executive has any rights in the results and proceeds of the Executive’s service to the Company that cannot be assigned in the manner described herein, the Executive agrees to unconditionally waive the enforcement of such rights. The
Executive hereby waives any and all currently existing and future monetary rights in and to the Inventions and all patents and other registrations for intellectual property that may issue thereon, including, without limitation, any rights that would
otherwise accrue to the Executive’s benefit by virtue of the Executive being an employee of or other service provider to the Company. 

 (f) RETURN OF COMPANY PROPERTY. On the date of the Executive’s termination of employment with the Company for any reason (or at any time prior thereto at the Company’s request), the
Executive shall return all property belonging to the Company or its affiliates (including, but not limited to, any Company-provided laptops, computers, cell phones, wireless electronic mail devices or other equipment, or documents and property
belonging to the Company). The Executive may retain the Executive’s rolodex and similar address books provided that such items only include contact information. 
 (g) REASONABLENESS OF COVENANTS. In signing this Agreement, the Executive gives the Company assurance that the Executive has carefully read and considered all of the terms and conditions of this
Agreement, including the restraints imposed under this Section 11 hereof. The Executive agrees that these restraints are necessary for the reasonable and proper protection of the Company and its affiliates and their Confidential
Information and that each and every one of the restraints is reasonable in respect to subject matter, length of time and geographic area, and that these restraints, individually or in the aggregate, will not prevent the Executive from obtaining
other suitable employment during the period in which the Executive is bound by the restraints. The Executive agrees that, before providing services, whether as an employee or consultant, to any entity during the period of time that the Executive is
subject to the constraints in Section 11(b) hereof, the Executive will provide a copy of this Agreement (including, without limitation, this Section 11) to such entity, and such entity shall acknowledge to the Company in
writing that it has read this Agreement. The Executive acknowledges that each of these covenants has a unique, very substantial and immeasurable value to the Company and its affiliates and that the Executive has sufficient assets and skills to
provide a livelihood while such covenants remain in force. It is also agreed that each of the Company’s affiliates will have the right to enforce all of the Executive’s obligations to that affiliate under this Agreement, including without
limitation pursuant to this Section 11. 

  
 15 

 (h) REFORMATION. If it is determined by a court of competent jurisdiction in
any state that any restriction in this Section 11 is excessive in duration or scope or is unreasonable or unenforceable under applicable law, it is the intention of the parties that such restriction may be modified or amended by the
court to render it enforceable to the maximum extent permitted by the laws of that state.  
 (i) TOLLING.
In the event of any violation of the provisions of this Section 11, the Executive acknowledges and agrees that the post-termination restrictions contained in this Section 11 shall be extended by a period of time equal to
the period of such violation, it being the intention of the parties hereto that the running of the applicable post-termination restriction period shall be tolled during any period of such violation.  

(j) SURVIVAL OF PROVISIONS. The obligations contained in Sections 11 and 12 hereof shall survive the
termination or expiration of the Employment Term and the Executive’s employment with the Company and shall be fully enforceable thereafter.  
 12. COOPERATION. Upon the receipt of reasonable notice from the Company (including outside counsel), the Executive agrees that while employed by the Company and thereafter, the Executive will
respond and provide information with regard to matters in which the Executive has knowledge as a result of the Executive’s employment with the Company, and will provide reasonable assistance to the Company, its affiliates and their respective
representatives in defense of any claims that may be made against the Company or its affiliates, and will provide reasonable assistance to the Company and its affiliates in the prosecution of any claims that may be made by the Company or its
affiliates, to the extent that such claims may relate to the period of the Executive’s employment with the Company (collectively, the “Claims”). The Executive agrees to promptly inform the Company if the Executive becomes aware
of any lawsuits involving Claims that may be filed or threatened against the Company or its affiliates. The Executive also agrees to promptly inform the Company (to the extent that the Executive is legally permitted to do so) if the Executive is
asked to assist in any investigation of the Company or its affiliates (or their actions) or another party attempts to obtain information or documents from the Executive (other than in connection with any litigation or other proceeding in which the
Executive is a party-in-opposition) with respect to matters the Executive believes in good faith to relate to any investigation of the Company or its affiliates, in each case, regardless of whether a lawsuit or other proceeding has then been filed
against the Company or its affiliates with respect to such investigation, and shall not do so unless legally required. During the pendency of any litigation or other proceeding involving Claims, the Executive shall not communicate with anyone (other
than the Executive’s attorneys and tax and/or financial advisors and except to the extent that the Executive determines in good faith is necessary in connection with the performance of the Executive’s duties hereunder) with respect to the
facts or subject matter of any pending or potential litigation or regulatory or administrative proceeding involving the Company or any of its affiliates without giving prior written notice to the Company or the Company’s counsel; provided,
however, nothing herein shall prohibit Executive providing testimony or information as compelled or required by law. Upon presentation of appropriate documentation, the Company shall pay or reimburse the Executive for all reasonable out-of-pocket
travel, duplicating or telephonic expenses incurred by the Executive in complying with this Section 12.  

  
 16 

 13. EQUITABLE RELIEF AND OTHER REMEDIES. The Executive acknowledges and agrees that
the Company’s remedies at law for a breach or threatened breach of any of the provisions of Section 11 or Section 12 hereof would be inadequate and, in recognition of this fact, the Executive agrees that, in the event of
such a breach or threatened breach, in addition to any remedies at law, the Company shall be entitled to seek equitable relief in the form of specific performance, a temporary restraining order, a temporary or permanent injunction or any other
equitable remedy which may then be available, without the necessity of showing actual monetary damages. In the event of a violation by the Executive of Section 11 or Section 12 hereof, any severance being paid to the
Executive pursuant to this Agreement or otherwise shall immediately cease, and any severance previously paid to the Executive shall be immediately repaid to the Company. 
 14. NO ASSIGNMENTS. This Agreement is personal to each of the parties hereto. Except as provided in this Section 14 hereof, no party may assign or delegate any rights or obligations
hereunder without first obtaining the written consent of the other party hereto. The Company may assign this Agreement to any successor to all or substantially all of the business and/or assets of the Company, provided that the Company shall
require such successor to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement,
“Company” shall mean the Company and any successor to its business and/or assets, which assumes and agrees to perform the duties and obligations of the Company under this Agreement by operation of law or otherwise.

 15. NOTICE. For purposes of this Agreement, notices and all other communications provided for in this Agreement
shall be in writing and shall be deemed to have been duly given (a) on the date of delivery, if delivered by hand, (b) on the date of transmission, if delivered by confirmed facsimile or electronic mail, (c) on the first business day
following the date of deposit, if delivered by guaranteed overnight delivery service, or (d) on the fourth business day following the date delivered or mailed by United States registered or certified mail, return receipt requested, postage
prepaid, addressed as follows:  
  

	
	 If to the Executive:

	
	 At the address (or to the facsimile number) shown in

	 the books and records of the Company.

  

							
	 If to the Company:
	 		 	
			
	
                           
                                         
                                         

	 		 	
			
	
                           
                                         
                                         
 
	 		 	
			
	
                           
                                         
                                         
 
	 		 	
			
	
Attention:                        
                                         
                        
	 		 	

 or to such other address as either party may have furnished to the other in writing in accordance herewith, except that
notices of change of address shall be effective only upon receipt. 

  
 17 

 16. SECTION HEADINGS; INCONSISTENCY. The section headings used in this Agreement are
included solely for convenience and shall not affect, or be used in connection with, the interpretation of this Agreement. In the event of any inconsistency between the terms of this Agreement and any form, award, plan or policy of the Company, the
terms of this Agreement shall govern and control.  
 17. SEVERABILITY. The provisions of this Agreement shall be
deemed severable. The invalidity or unenforceability of any provision of this Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality
or enforceability of any provision of this Agreement in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by applicable law.  

18. COUNTERPARTS. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all
of which together will constitute one and the same instrument.  
 19. GOVERNING LAW. This Agreement, the rights
and obligations of the parties hereto, and any claims or disputes relating thereto, shall be governed by and construed in accordance with the laws of the State of Ohio (without regard to its choice of law provisions). EACH OF THE PARTIES HERETO
WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE EXECUTIVE’S EMPLOYMENT BY THE COMPANY OR ANY AFFILIATE OF THE COMPANY, OR THE
EXECUTIVE’S OR THE COMPANY’S PERFORMANCE UNDER, OR THE ENFORCEMENT OF, THIS AGREEMENT.  
 20. MISCELLANEOUS.
No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing and signed by the Executive and such officer or director as may be designated by the Board. No waiver by
either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or
conditions at the same or at any prior or subsequent time. This Agreement together with all exhibits hereto sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersedes any and all prior
agreements or understandings between the Executive and the Company with respect to the subject matter hereof. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either
party which are not expressly set forth in this Agreement.  
 21. REPRESENTATIONS. The Executive represents
and warrants to the Company that (a) the Executive has the legal right to enter into this Agreement and to perform all of the obligations on the Executive’s part to be performed hereunder in accordance with its terms, and (b) the
Executive is not a party to any agreement or understanding, written or oral, and is not subject to any restriction, which, in either case, could prevent the Executive from entering into this Agreement or performing all of the Executive’s duties
and obligations hereunder. In addition, the Executive acknowledges that the Executive is aware of Section 304 (Forfeiture of Certain Bonuses and Profits) of the Sarbanes-Oxley Act of 2002 and the right of the Company to be reimbursed for
certain payments to the Executive in compliance therewith. 

  
 18 

 22. TAX MATTERS. 

(a) WITHHOLDING. The Company may withhold from any and all amounts payable under this Agreement or otherwise such federal, state
and local taxes as may be required to be withheld pursuant to any applicable law or regulation. In the event that the Company fails to withhold any taxes required to be withheld by applicable law or regulation, the Executive agrees to indemnify the
Company for any amount paid with respect to any such taxes, together with any interest, penalty and/or expense related thereto. 

(b) SECTION 409A COMPLIANCE. 
  

	 	(i)	The intent of the parties is that payments and benefits under this Agreement comply with Internal Revenue Code Section 409A and the regulations and guidance
promulgated thereunder (collectively “Code Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. In no event whatsoever shall the Company be liable
for any additional tax, interest or penalty that may be imposed on the Executive by Code Section 409A or damages for failing to comply with Code Section 409A. 

 

	 	(ii)	A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits
upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement, references to a
“termination,” “termination of employment” or like terms shall mean “separation from service.” Notwithstanding anything to the contrary in this Agreement, if the Executive is deemed on the date of termination to be a
“specified employee” within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any payment or the provision of any benefit that is considered deferred compensation under Code Section 409A payable on
account of a “separation from service,” such payment or benefit shall not be made or provided until the date which is the earlier of (A) the expiration of the six (6)-month period measured from the date of such “separation from
service” of the Executive, and (B) the date of the Executive’s death, to the extent required under Code Section 409A. Upon the expiration of the foregoing delay period, all payments and benefits delayed pursuant to this
Section 22(b)(ii) (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to the Executive in a lump sum, and any remaining payments and benefits due
under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein. 

  
 19 

	 	(iii)	To the extent that reimbursements or other in-kind benefits under this Agreement constitute “nonqualified deferred compensation” for purposes of Code
Section 409A, (A) all such expenses or other reimbursements hereunder shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by the Executive, (B) any right to
such reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (C) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way
affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year. 

  

	 	(iv)	For purposes of Code Section 409A, the Executive’s right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive
a series of separate and distinct payments. Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the specified period shall be within the sole discretion of the
Company. 

  

	 	(v)	Notwithstanding any other provision of this Agreement to the contrary, in no event shall any payment under this Agreement that constitutes “nonqualified deferred
compensation” for purposes of Code Section 409A be subject to offset by any other amount unless otherwise permitted by Code Section 409A. 

 23. REIMBURSEMENT OF EXECUTIVE’S ATTORNEYS’ FEES. The Company shall reimburse Executive for his legal fees incurred in connection with the negotiation and preparation of this
Agreement. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 20 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date
first written above. 
  

			
	COMPANY
		
	By:	 	/s/ Richard A. Snell
	Name:	 	 
	Title:	 	 
	
	EXECUTIVE
		
		 	/s/ Richard Lavin

 Signature Page to Employment Agreement 

  
 21 

 EXHIBIT A 

GENERAL RELEASE 
 I,                     , in consideration of and subject to the performance by Commercial Vehicle Group,
Inc. (together with its subsidiaries, the “Company”), of its obligations under the Employment Agreement dated as of [August __], 2013 (the “Agreement”), do hereby release and forever discharge as of the date
hereof the Company and its respective affiliates and all present, former and future managers, directors, officers, employees, successors and assigns of the Company and its affiliates and direct or indirect owners (collectively, the “Released
Parties”) to the extent provided below (this “General Release”). The Released Parties are intended to be third-party beneficiaries of this General Release, and this General Release may be enforced by each of them in
accordance with the terms hereof in respect of the rights granted to such Released Parties hereunder. Terms used herein but not otherwise defined shall have the meanings given to them in the Agreement. 

1. I understand that any payments or benefits paid or granted to me under Section 9 of the Agreement represent, in part,
consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive certain of the payments and benefits specified in Section 9 of the Agreement
unless I execute this General Release and do not revoke this General Release within the time period permitted hereafter. Such payments and benefits will not be considered compensation for purposes of any employee benefit plan, program, policy or
arrangement maintained or hereafter established by the Company or its affiliates. 
 2. Except as provided in paragraphs 4 and 5
below and except for the provisions of the Agreement which expressly survive the termination of my employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever discharge
the Company and the other Released Parties from any and all claims, suits, controversies, actions, causes of action, cross-claims, counter-claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other
damages, claims for costs and attorneys’ fees, or liabilities of any nature whatsoever in law and in equity, both past and present (through the date that this General Release becomes effective and enforceable) and whether known or unknown,
suspected, or claimed against the Company or any of the Released Parties which I, my spouse, or any of my heirs, executors, administrators or assigns, may have, which arise out of or are connected with my employment with, or my separation or
termination from, the Company (including, but not limited to, any allegation, claim or violation, arising under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967,
as amended (including the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the
Employee Retirement Income Security Act of 1974; any applicable Executive Order Programs; the Fair Labor Standards Act; or their state or local counterparts; or under any other federal, state or local civil or human rights law, or under any other
local, state, or federal law, regulation or ordinance; or under any public policy, 

  
 A-1

 
contract or tort, or under common law; or arising under any policies, practices or procedures of the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional
distress, defamation; or any claim for costs, fees, or other expenses, including attorneys’ fees incurred in these matters) (all of the foregoing collectively referred to herein as the “Claims”). 

3. I represent that I have made no assignment or transfer of any right, claim, demand, cause of action, or other matter covered by
paragraph 2 above. 
 4. I agree that this General Release does not waive or release any rights or claims that I may have under
the Age Discrimination in Employment Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation from employment with the Company in compliance with the terms of the Agreement shall not serve as
the basis for any claim or action (including, without limitation, any claim under the Age Discrimination in Employment Act of 1967). 
 5. I agree that I hereby waive all rights to sue or obtain equitable, remedial or punitive relief from any or all Released Parties of any kind whatsoever in respect of any Claim, including, without
limitation, reinstatement, back pay, front pay, and any form of injunctive relief. Notwithstanding the above, I further acknowledge that I am not waiving and am not being required to waive any right that cannot be waived under law, including the
right to file an administrative charge or participate in an administrative investigation or proceeding; provided, however, that I disclaim and waive any right to share or participate in any monetary award resulting from the prosecution
of such charge or investigation or proceeding. Additionally, I am not waiving (i) any right or claim to any severance benefits or other benefits relating to termination of employment to which I am entitled under the Agreement, (ii) any
right or claim relating to directors’ and officers’ liability insurance coverage or any right of indemnification under the Company’s organizational documents or otherwise, (iii) any right or claim as an equity or security holder
in the Company or its affiliates, including, without limitation, any rights under any equity incentive or stock option grant or plan, (iv) any right or claim for reimbursement of business expenses incurred prior to the employment termination
date, and (v) any right or claim with respect to any vested benefits under any employee benefit plans, including without limitation any health, welfare, retirement, pension, profit-sharing or deferred compensation plan. 

6. In signing this General Release, I acknowledge and intend that it shall be effective as a bar to each and every one of the Claims
hereinabove mentioned or implied. I expressly consent that this General Release shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected Claims
(notwithstanding any state or local statute that expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned or implied. I
acknowledge and agree that this waiver is an essential and material term of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree that in the event I should bring a Claim
seeking damages against the Company, or in the event I should seek to recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release shall serve as a complete defense to such Claims to the maximum extent
permitted by law. I further agree that I am not aware of any pending claim of the type described in paragraph 2 above as of the execution of this General Release. 

  
 A-2

 7. I agree that neither this General Release, nor the furnishing of the consideration for
this General Release, shall be deemed or construed at any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct. 
 8. I agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay all costs and expenses of defending against the suit incurred by the Released Parties,
including reasonable attorneys’ fees. 
 9. I agree that this General Release and the Agreement are confidential and agree
not to disclose any information regarding the terms of this General Release or the Agreement, except to my immediate family and any tax, legal or other counsel I have consulted regarding the meaning or effect hereof or as required by law, and I will
instruct each of the foregoing not to disclose the same to anyone; provided, however, if this General Release and/or the Agreement is or becomes publicly filed by the Company, or if the terms of this General Release and/or the Agreement is or
becomes publicly disclosed by the Company, I shall have no confidentiality obligation under this Section 9. 
 10. Any
non-disclosure provision in this General Release does not prohibit or restrict me (or my attorney) from responding to any inquiry about this General Release or its underlying facts and circumstances by the Securities and Exchange Commission (SEC),
the Financial Industry Regulatory Authority (FINRA), any other self-regulatory organization or any governmental entity. 
 11. I
hereby acknowledge that certain provisions of the Agreement, including Sections 11 of the Agreement, shall survive my execution of this General Release in accordance with the terms of the Agreement. 

12. I represent that I am not aware of any claim by me other than the claims that are released by this General Release. I acknowledge that
I may hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the release set forth in paragraph 2 above and which, if known or suspected at the time of
entering into this General Release, may have materially affected this General Release and my decision to enter into it. 
 13.
Notwithstanding anything in this General Release to the contrary, this General Release shall not relinquish, diminish, or in any way affect any rights or claims arising out of any breach by the Company or by any Released Party of the Agreement after
the date hereof. 
 14. Whenever possible, each provision of this General Release shall be interpreted in, such manner as to be
effective and valid under applicable law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or
unenforceability shall not affect any other provision or any other jurisdiction, but this General Release shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained
herein. 

  
 A-3

 BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT: 

 

	 	1.	I HAVE READ IT CAREFULLY; 

  

	 	2.	I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO, RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF
1967, AS AMENDED, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963, THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED; 

 

	 	3.	I VOLUNTARILY CONSENT TO EVERYTHING IN IT; 

  

	 	4.	I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN
VOLITION; 

  

	 	5.	I HAVE HAD AT LEAST [21][45] DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT, AND THE CHANGES MADE SINCE MY RECEIPT OF THIS RELEASE ARE NOT
MATERIAL OR WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED [21][45]-DAY PERIOD; 

  

	 	6.	I UNDERSTAND THAT I HAVE SEVEN (7) DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE
REVOCATION PERIOD HAS EXPIRED; 

  

	 	7.	I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY COUNSEL RETAINED TO ADVISE ME WITH RESPECT TO IT; AND 

 

	 	8.	I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED
REPRESENTATIVE OF THE COMPANY AND BY ME. 

  

									
	SIGNED:	 	 	 		  	DATED:	  	 

  
 A-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}]]